Mabpharm Limited (HKG:2181)

Mabpharm Revenue

Mabpharm had revenue of 274.18M CNY in the half year ending June 30, 2025, with 522.86% growth. This brings the company's revenue in the last twelve months to 423.93M, up 179.59% year-over-year. In the year 2024, Mabpharm had annual revenue of 258.23M with 196.27% growth.

• Revenue (ttm): 423.93M CNY
• Revenue Growth: +179.59%
• P/S Ratio: 4.53
• Revenue / Employee: 1.11M CNY
• Employees: 383
• Market Cap: 2.10B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	258.23M	171.07M	196.27%
Dec 31, 2023	87.16M	31.24M	55.87%
Dec 31, 2022	55.92M	-26.96M	-32.53%
Dec 31, 2021	82.88M	-	-
Dec 31, 2020	-	-	-